Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

57 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Carboplatin and gemcitabine in the palliative treatment of stage IV non-small cell lung cancer: definitive results of a phase II trial.
Tassinari D, Fochessati F, Arcangeli V, Sartori S, Agostini V, Fantini M, Genestreti G, Grassia S, Ioli G, Imola M, Iorio D, Mianulli AM, Monticelli G, Oliverio G, Panzini I, Papi M, Poggi B, Polselli A, Pulini S, Tamburini E, Fattori PP, Ravaioli A. Tassinari D, et al. Among authors: oliverio g. Tumori. 2004 Jan-Feb;90(1):54-9. doi: 10.1177/030089160409000113. Tumori. 2004. PMID: 15143973 Clinical Trial.
[Chemotherapy in extended small-cell lung cancer. Retrospective analysis of two different series of patients treated with carboplatin and etoposide or ciclophosphamide-epidoxorubicin and etoposide].
Tassinari D, Genestreti G, Pasquini E, Fantini M, Poggi B, Tamburini E, Papi M, Ioli G, Oliverio G, Fochessati F, Arcangeli V, Agostini V, Mianulli AM, Imola M, Fattori PP, Ravaioli A. Tassinari D, et al. Among authors: oliverio g. Recenti Prog Med. 2005 May;96(5):234-9. Recenti Prog Med. 2005. PMID: 15977652 Italian.
Randomized phase II study with two gemcitabine- and docetaxel-based combinations as first-line chemotherapy for metastatic non-small cell lung cancer.
Passardi A, Cecconetto L, Dall'agata M, Dazzi C, Pasquini E, Oliverio G, Zumaglini F, Zoli W, Nanni O, Milandri C, Frassineti GL, Amadori D. Passardi A, et al. Among authors: oliverio g. J Transl Med. 2008 Oct 31;6:65. doi: 10.1186/1479-5876-6-65. J Transl Med. 2008. PMID: 18976450 Free PMC article. Clinical Trial.
The effect of endocrine responsiveness on high-risk breast cancer treated with dose-intensive chemotherapy: results of International Breast Cancer Study Group Trial 15-95 after prolonged follow-up.
Colleoni M, Sun Z, Martinelli G, Basser RL, Coates AS, Gelber RD, Green MD, Peccatori F, Cinieri S, Aebi S, Viale G, Price KN, Goldhirsch A; International Breast Cancer Study Group. Colleoni M, et al. Ann Oncol. 2009 Aug;20(8):1344-51. doi: 10.1093/annonc/mdp024. Epub 2009 May 25. Ann Oncol. 2009. PMID: 19468030 Free PMC article. Clinical Trial.
Role of biological markers in the clinical outcome of colon cancer.
Nanni O, Volpi A, Frassineti GL, De Paola F, Granato AM, Dubini A, Zoli W, Scarpi E, Turci D, Oliverio G, Gambi A, Amadori D. Nanni O, et al. Among authors: oliverio g. Br J Cancer. 2002 Oct 7;87(8):868-75. doi: 10.1038/sj.bjc.6600569. Br J Cancer. 2002. PMID: 12373601 Free PMC article. Clinical Trial.
57 results